- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00173186
Aortic Regurgitation After Surgical Repair of Outlet-Type Ventricular Septal Defect
Study Overview
Status
Detailed Description
Progression of aortic regurgitation (AR) in repaired outlet (juxta-arterial, muscular outlet and perimembranous outlet) ventricular septal defect (VSD) remains unclear.
From 1987 to 2002, 411 patients with complete follow-up after repair of outlet VSD constituted the study population. Study end point was aortic valve replacement or mortality.
Aortic valve replacement was performed in seventeen patients (4.1%), in whom logistic regression showed only the severity of preoperative AR and age at VSD repair as the predictors. After excluding the eleven patients with endocarditis from analysis, there were 377 patients with none to mild AR (Group I) and 23 with moderate to severe AR (Group II) preoperatively. Total follow-up was 2,230 person-years. After VSD repair, the 5- and 10-year freedom from aortic valve replacement in Group I was 100%, and in Group II 50.2%. In Group II, ten patients received aortic valve replacement and 8 underwent valvuloplasty with VSD repair. One patient needed valve replacement four years later. Age at VSD repair was the predictor for aortic valve replacement. In Group I, AR progressed in four patients (1.2%, two juxta-arterial and two perimembranous outlet) 3.5 to 7.9 years later and was associated with aortic valvar or subvalvar anomalies. The event-free curves in three outlet types VSD showed no differences.
Although AR progressed rarely (probably not in muscular outlet type) in repaired outlet types VSD with none to mild preoperative AR, in the presence of aortic valvar or subvalvar anomalies, early surgical repair of the VSD is still warranted.
Study Type
Enrollment
Contacts and Locations
Study Contact
- Name: Mei-Hwan Wu, MD, PhD
- Phone Number: 5126 886-2-23123456
- Email: mhwu@ha.mc.ntu.edu.tw
Study Contact Backup
- Name: Shuenn-Nan Chiu, MD
- Phone Number: 5126 886-2-23123456
- Email: michael@ha.mc.ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 100
- Recruiting
- Department of Pediatrics, National Taiwan University Hospital
-
Contact:
- Mei-Hwan Wu, MD, PhD
- Phone Number: 5126 886-2-23123456
- Email: mhwu@ha.mc.ntu.edu.tw
-
Contact:
- Shuenn-Nan Chiu, MD
- Phone Number: 5126 886-2-23123456
- Email: michael@ha.mc.ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ventricular septal defect patients receiving total repair from Jan, 1987 to Dec, 2002.
- follow up more than 1 year after operation
Exclusion Criteria:
- complex cardiac lesions
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Investigators
- Study Chair: Mei-Hwan Wu, MD, PhD, National Taiwan University Hospital
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9461700517
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Insufficiency
-
CSD Labs GmbHCompletedAortic Stenosis | Mitral Insufficiency | Tricuspid Regurgitation | Aortic Insufficiency | Mitral Insufficiency and Aortic Stenosis | Insufficiency, Pulmonary | Insufficiency, TricuspidAustria
-
JenaValve Technology, Inc.Active, not recruitingAortic Valve Disease | Aortic Regurgitation | Aortic Valve Insufficiency | Aortic InsufficiencyUnited States
-
Assistance Publique - Hôpitaux de ParisEuropean Association of Cardiovascular ImagingNot yet recruitingAortic Valve Stenosis | Aortic Valve Disease | Heart Valve Diseases | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Mitral Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Tricuspid Valve Insufficiency | Mitral Valve Disease | Tricuspid Valve Disease | Mitral Valve Insufficiency and... and other conditionsFrance
-
Biostable Science & EngineeringCompletedAortic InsufficiencyGermany, Czech Republic
-
Chengdu Silara Meditech Inc.Not yet recruiting
-
Atlantic Health SystemRecruitingMitral Regurgitation | Aortic RegurgitationUnited States
-
Ospedale San RaffaeleUnknownMitral Regurgitation | Aortic RegurgitationItaly
-
Michele De BonisCompletedMitral Regurgitation | Aortic RegurgitationItaly
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaTerminatedAortic Regurgitation | Aortic Valve Insufficiency | Regurgitation, Aortic Valve | Aortic Valve | Aortic IncompetenceKorea, Republic of
-
Saint Petersburg State University, RussiaNot yet recruitingIschemic Heart Disease | Mitral Insufficiency | Aortic Stenosis, Severe | Mitral Stenosis | Aortic Insufficiency | Ascending Aortic Aneurysm | Mitral Stenosis With Insufficiency | Tricuspid InsufficiencyRussian Federation